In prostatic carcinoma, the expression of VEGF-C mRNA in the primary tumour is significantly higher in lymph node-positive patients compared to lymph node-negative patients (Tsurusaki et al, 1999). This evidence concerns the gene VEGFC and prostate carcinoma.